Noah Davidsohn
Company: Rejuvenate Bio
Job title: Chief Scientific Officer
Seminars:
Panel Discussion: Deliberating the Benefits & Challenges of Current Preclinical Models to Move Towards Translational Success 2:30 pm
Increasing the relevance and accessibility of animal models to ease and shorten the drug discovery process How are rats and mice used to replicate NASH? Assessing the ability to recapitulate more than one aspect of diseaseRead more
day: Day 1 Seminar A Post-Lunch Tracks
Harnessing Gene Therapy for Prevalent Metabolic Indications 2:00 pm
Novel preclinical animal models to assess metabolic dysfunction Unravelling a class of new targets to optimize treatment of NASH and obesity Detailing the newest data and next steps forwardRead more
day: Day 1 Seminar A Post-Lunch Tracks